Discover
MLYS
Mineralys Therapeutics, Inc.
28.02
2 x 20.83
1 x 27.47
bid
ask
+
0.04
0.14%
2 @ 04:00 PM
28.02 +0.00 (0.00%)
| Ytd | -22.79% | |
| 1y | -29.72% |
27.38
day range
28.13
22.30
52 week range
47.65
| Open | 27.77 | Prev Close | 27.98 | Low | 27.38 | High | 28.13 | Mkt Cap | 2.48B |
| Vol | 3.79M | Avg Vol | 1.10M | EPS | -4.20 | P/E | N/A | Forward P/E | -11.21 |
| Beta | 0.68 | Short Ratio | 11.88 | Inst. Own | 117.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 27.13 | 200-d Avg | 29.00 | 1yr Est | 48.50 |
| Income Statement | |||
| Operating Expenses | 246.04M | ||
| Research and Development Expense | 221.38M | ||
| Selling, General and Administrative Expense | 24.66M | ||
| Operating Income | -246.04M | ||
| Net Income | -241.07M | ||
| Net Income Common Stock | -241.07M | ||
| Net Income Common Stock (USD) | -241.07M | ||
| Consolidated Income | -241.07M | ||
| Earnings per Basic Share | -2.85 | ||
| Earnings per Basic Share (USD) | -2.85 | ||
| Earnings per Diluted Share | -2.85 | ||
| Earning Before Interest & Taxes (EBIT) | -241.07M | ||
| Earning Before Interest & Taxes (USD) | -241.07M | ||
| Weighted Average Shares | 84.73M | ||
| Weighted Average Shares Diluted | 84.73M | ||
| Balance Sheet | |||
| Cash and Equivalents | 138.27M | ||
| Cash and Equivalents (USD) | 138.27M | ||
| Investments | 523.14M | ||
| Investments Current | 523.14M | ||
| Current Assets | 665.80M | ||
| Property, Plant & Equipment Net | 27.00K | ||
| Total Assets | 667.85M | ||
| Total Debt | 97.62M | ||
| Current Liabilities | 19.32M | ||
| Debt Non-Current | 97.62M | ||
| Total Liabilities | 116.94M | ||
| Accumulated Retained Earnings (Deficit) | -737.58M | ||
| Shareholders Equity | 550.92M | ||
| Shareholders Equity (USD) | 550.92M | ||
| Assets Non-Current | 2.05M | ||
| Total Debt (USD) | 97.62M | ||
| Liabilities Non-Current | 97.62M | ||
| Trade and Non-Trade Payables | 1.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.00K | ||
| Net Cash Flow from Financing | 243.26M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 25.49M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -200.00M | ||
| Issuance (Purchase) of Equity Shares | 146.79M | ||
| Issuance (Repayment) of Debt Securities | 96.49M | ||
| Net Cash Flow from Investing | -185.22M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 14.78M | ||
| Net Cash Flow from Operations | -32.56M | ||
| Share Based Compensation | 7.36M | ||